Latest Period
Q2 2026
Security Snapshot
MDxHealth SA - Ordinary Shares (MDXH) Institutional Ownership
CUSIP: B5950S113
13F Institutional Holders and Ownership History from Q4 2023 to Q2 2026
Institutions Reporting
26
Shares (Excl. Options)
16,588,839
Price
$0.41
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares
- Symbol
- MDXH on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 16,588,839
- Total 13F value
- $6,791,726
- Portfolio coverage rank
- 0%
- Share change
- -8,156,217
- Value change
- -$22,329,734
- Number of holders
- 26
- Shares outstanding
- 95,174,297
- SEC-reported price per share
- $0.46
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MDXH - MDxHealth SA - Ordinary Shares is tracked under CUSIP B5950S113.
- 26 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 50 to 26 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $56,866,992 to $6,791,726.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 26 institutions filings for Q2 2026.
Security key
B5950S113
Latest holder period
Q2 2026
13F holders
26
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
MDXH full holder history
MDxHealth SA SEC filings
MDxHealth SA company facts
MDxHealth SA insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP B5950S113:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
MDXH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 20% | +99% | $9,465,084 | +$6,943,917 | 18,558,988 | +275% | Laurence W. Lytton | 13 Aug 2026 |
| EXACT SCIENCES CORP | 12% | $22,608,510 | 6,441,171 | Genomic Health, Inc. | 09 Jan 2026 |
As of 30 Jun 2026, 26 institutional investors reported holding 16,588,839 shares of MDxHealth SA - Ordinary Shares (MDXH). This represents 17% of the company’s total 95,174,297 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
17%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Bleichroeder LP | 7.8% | 7,378,333 | 0% | 0.54% | $3,029,544 |
| MVM Partners, LLC | 4.9% | 4,700,457 | 0% | 100% | $1,911,206 |
| PERKINS CAPITAL MANAGEMENT INC | 1.5% | 1,411,891 | -4.4% | 0.44% | $579,722 |
| CITADEL ADVISORS LLC | 0.54% | 509,674 | +755% | 0% | $209,272 |
| JANE STREET GROUP, LLC | 0.53% | 503,219 | 0% | $206,622 | |
| GSA CAPITAL PARTNERS LLP | 0.51% | 481,985 | +4245% | 0.01% | $198,000 |
| RENAISSANCE TECHNOLOGIES LLC | 0.34% | 325,084 | +6.7% | 0% | $133,479 |
| MILLENNIUM MANAGEMENT LLC | 0.24% | 228,510 | -58% | 0% | $93,826 |
| Squarepoint Ops LLC | 0.21% | 200,281 | 0% | $82,235 | |
| XTX Topco Ltd | 0.2% | 195,039 | +417% | 0% | $80,083 |
| HRT FINANCIAL LP | 0.19% | 184,477 | +1529% | 0% | $75,000 |
| BlackRock, Inc. | 0.15% | 147,063 | +41% | 0% | $60,384 |
| Virtu Financial LLC | 0.14% | 134,178 | 0% | $55,000 | |
| Ground Swell Capital, LLC | 0.09% | 88,114 | 0.04% | $36,180 | |
| Tower Research Capital LLC (TRC) | 0.04% | 36,549 | 0% | $15,007 | |
| FAS Wealth Partners, Inc. | 0.02% | 22,625 | 0% | 0% | $9,290 |
| Lido Advisors, LLC | 0.02% | 20,253 | +93% | 0% | $8,316 |
| Intesa Sanpaolo Wealth Management | 0.01% | 10,000 | 0% | 0% | $4,106 |
| Cambridge Investment Research Advisors, Inc. | 0.01% | 10,000 | 0% | 0% | $4,000 |
| MORGAN STANLEY | 0% | 764 | -95% | 0% | $313 |
| WELLS FARGO & COMPANY/MN | 0% | 200 | 0% | 0% | $82 |
| Monetary Solutions, Ltd | 0% | 85 | 0% | 0% | $35 |
| SBI Securities Co., Ltd. | 0% | 29 | 0% | 0% | $12 |
| BARCLAYS PLC | 0% | 16 | -98% | 0% | $7 |
| Farther Finance Advisors, LLC | 0% | 10 | 0% | 0% | $4 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q2 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 16,588,839 | $6,791,726 | -$22,329,734 | $0.41 | 26 |
| 2026 Q1 | 24,745,056 | $56,866,992 | +$66,259 | $2.30 | 50 |
| 2025 Q4 | 24,323,813 | $86,848,001 | +$5,220,726 | $3.57 | 56 |
| 2025 Q3 | 22,749,321 | $105,692,503 | +$5,766,815 | $4.65 | 41 |
| 2025 Q2 | 21,537,133 | $47,550,058 | +$741,879 | $2.21 | 21 |
| 2025 Q1 | 21,234,231 | $30,058,598 | -$2,917,190 | $1.42 | 21 |
| 2024 Q4 | 22,490,413 | $53,208,269 | -$574,276 | $2.37 | 24 |
| 2024 Q3 | 22,821,283 | $47,397,762 | +$28,193,800 | $2.08 | 22 |
| 2024 Q2 | 8,940,490 | $21,004,213 | -$1,053,650 | $2.39 | 9 |
| 2024 Q1 | 9,344,851 | $24,179,980 | -$695,621 | $2.59 | 13 |
| 2023 Q4 | 9,597,973 | $37,538,305 | +$37,538,305 | $3.94 | 12 |